arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide has been researched along with debrisoquin in 1 studies
*Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. [MeSH]
*Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. [MeSH]
| Studies (arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide) | Trials (arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide) | Recent Studies (post-2010) (arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide) | Studies (debrisoquin) | Trials (debrisoquin) | Recent Studies (post-2010) (debrisoquin) |
|---|---|---|---|---|---|
| 13 | 1 | 1 | 890 | 89 | 17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smyth, JF | 1 |
1 other study(ies) available for arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide and debrisoquin
| Article | Year |
|---|---|
Cancer genetics and cell and molecular biology. Is this the way forward?
Topics: Antihypertensive Agents; Antineoplastic Agents; Debrisoquin; Extracellular Matrix; Humans; Lung Neoplasms; Metalloendopeptidases; Oligopeptides; Peptides; Precancerous Conditions | 1996 |